Also available in Persian — نسخه فارسی EN فا
❓ Unknown

Fecal Microbiota Transplantation May Enhance Cancer Treatment by Reducing Need for Steroids

Yesterday September 15, 2026 1 min read 📰 Medical Xpress
📋 Key Takeaway

Researchers at The University of Texas MD Anderson Cancer Center have found that fecal microbiota transplantation (FMT) may help cancer patients experiencing immunotherapy-related colitis avoid steroids and immunosuppressive treatments. This research could have implications for cancer treatment approaches globally, including in Iran, where healthcare advancements are crucial.

🔍 Quick Context Guide
💡 Bottom Line: New research suggests that fecal microbiota transplantation may reduce the need for steroids in cancer treatment, potentially improving patient care.

👥 Key Players

The University of Texas MD Anderson Cancer Center MENTIONED
Leading cancer research institution
"They are at the forefront of cancer treatment research, influencing global practices including in Iran."

📰 What Happened

Researchers at The University of Texas MD Anderson Cancer Center discovered that fecal microbiota transplantation (FMT) could help cancer patients with immunotherapy-related colitis avoid the use of steroids and immunosuppressive treatments.

  • FMT targets the gut microbiome to potentially improve cancer treatment outcomes.
  • This research could lead to less reliance on steroids, which have significant side effects.

💡 Why It Matters

🇮🇷 For Iran: Advancements in cancer treatment are crucial for Iran, where healthcare resources are often limited and innovative treatments can improve patient outcomes.
🌍 Regional: If successful, this approach could enhance cancer care across the Middle East, where cancer rates are rising.
🌐 International: This research could shift global cancer treatment paradigms, emphasizing the role of the microbiome in therapy.

📚 Background

Fecal microbiota transplantation involves transferring gut microbiota from a healthy donor to a patient, which may help restore a balanced microbiome and improve health outcomes.

Gut microbiome and health Immunotherapy in cancer treatment
📡 Source: NEUTRAL
📊 Confidence: 70%
The findings are from a reputable cancer research institution, suggesting a focus on scientific evidence rather than political bias.

Targeting the gut microbiome with fecal microbiota transplantation (FMT) may help cancer patients with immunotherapy-related colitis avoid the need for steroids and other immunosuppressive treatments, according to researchers at The University of Texas MD Anderson Cancer Center.

🌐

Translated from the original and edited for English readers. View original source →

Translation confidence: 100%

📰 Related Coverage

⚖️ Independent Platform — Artesh.com is not affiliated with any government, military, or political organization. Editorial Policy →